Saverna Therapeutics AG
PrivateLast Round
Seed
Feb 1, 2020
Total Funding Raised
$1.57M
Company Overview
Saverna Therapeutics AG is a biotechnology company that develops an innovative drug discovery platform combining machine learning, fragment-based screening, and nuclear magnetic resonance spectroscopy to identify small molecule drugs targeting non-coding RNA.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saverna Therapeutics AG Comparables
Compare Saverna Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 85% | |
| Ribometrix | 84% | |
| Base4 Biotechnology | 84% |
Saverna Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2020 | ||||
| Grant | Apr 1, 2019 |
Saverna Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2024
Monthly visitors grew 394% MoM, from 36 to 178.
- Apr 1, 2019
$1.57M grant received
Saverna Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Saverna Therapeutics AG's valuation, stock price, and market status.
Is Saverna Therapeutics AG a public or private company?
Saverna Therapeutics AG is a private company.
What is the current stock price of Saverna Therapeutics AG?
Saverna Therapeutics AG is a private company with no public stock price. No recent secondary market data is available.
How much is Saverna Therapeutics AG worth (valuation)?
Valuation information for Saverna Therapeutics AG is not publicly available.
Can I buy Saverna Therapeutics AG stock?
Saverna Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Saverna Therapeutics AG's last funding round?
Saverna Therapeutics AG's most recent funding round was Seed on February 1, 2020.
Who are the main investors in Saverna Therapeutics AG?
Key investors in Saverna Therapeutics AG include Innosuisse.
Will Saverna Therapeutics AG IPO soon?
No public IPO plans have been announced for Saverna Therapeutics AG.
How can I track Saverna Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Saverna Therapeutics AG's secondary market activity and sign up for updates.